Skip to main content
Have a personal or library account? Click to login
Innovative Management of Rhythm Disorders in Adults with Congenital Heart Disease Cover

Innovative Management of Rhythm Disorders in Adults with Congenital Heart Disease

Open Access
|Jun 2026

References

  1. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010 Sep 28;56(14):1149-1157. doi: 10.1016/j.jacc.2010.03.085
  2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007 Jan 16;115(2):163-172. doi: 10.1161/CIRCULATIONAHA.106.627224
  3. Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct;11(10):e102-e165. doi: 10.1016/j.hrthm.2014.05.009
  4. Khairy P, Silka MJ, Moore JP, et al. Sudden cardiac death in congenital heart disease. Eur Heart J. 2022 Jun 6;43(22):2103-2115. doi: 10.1093/eurheartj/ehac104
  5. Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009 Oct 27;120(17):1679-1686. doi: 10.1161/CIRCULATIONAHA.109.866319
  6. Escudero C, Khairy P, Sanatani S. Electrophysiologic considerations in congenital heart disease and their relationship to heart failure. Can J Cardiol. 2013 Jul;29(7):821-829.
  7. Bessiere F, Mondesert B, Chaix MA, Khairy P. Arrhythmias in adults with congenital heart disease and heart failure. Heart Rhythm O2. 2021 Dec 17;2(6Part B):744-753. doi: 10.1016/j.hroo.2021.10.005
  8. Carlson SK, Patel AR, Chang PM. Bradyarrhythmias in congenital heart disease. Card Electrophysiol Clin. 2017 Jun;9(2):177-187. doi: 10.1016/j.ccep.2017.02.002
  9. Kamp A, Moore JP, Khairy P. How to perform catheter ablation of atrial tachyarrhythmia after the Fontan operation. Heart Rhythm. 2023 Jul;20(7):1048-1054. doi: 10.1016/j.hrthm.2023.03.023
  10. Waldmann V, Moore JP, Bessiere F, et al. Association between slowly conducting anatomical isthmuses and ventricular tachycardia inducibility in tetralogy of Fallot. JACC Clin Electrophysiol. 2026 Jan;12(1):31-40. doi: 10.1016/j.jacep.2025.08.008
  11. Mondesert B, Nair K, McLeod CJ, Khairy P. Technological advances in arrhythmia management applied to adults with congenital heart disease. Can J Cardiol. 2019 Dec;35(12):1708-1722. doi: 10.1016/j.cjca.2019.06.034
  12. Le Bloa M, Abadir S, Nair K, Mondesert B, Khairy P. New developments in catheter ablation for patients with congenital heart disease. Expert Rev Cardiovasc Ther. 2021 Jan;19(1):15-26. doi: 10.1080/14779072.2021.1847082
  13. Khairy P. Robotic magnetic-guided catheter ablation: an emerging treatment for congenital heart disease. Future Cardiol. 2025 Jan;21(1):1-3. doi: 10.1080/14796678.2024.2432812
  14. Krause U, Bergau L, Zabel M, Schneider HE, Muller MJ, Paul T. Pulsed field ablation of atrial fibrillation and atrial tachycardia in adult patients with congenital heart disease. Circ Arrhythm Electrophysiol. 2024 Jun;17(6):e012698. doi: 10.1161/CIRCEP.123.012698
  15. O’Leary ET, Feins EN, Davee J, et al. Intraoperative conduction mapping to reduce postoperative atrioventricular block in complex congenital heart disease. J Am Coll Cardiol. 2024 Nov 19;84(21):2102-2112. doi: 10.1016/j.jacc.2024.07.054
  16. Kharbanda RK, Moore JP, Lloyd MS, et al. Cardiac resynchronization therapy for adult patients with a failing systemic right ventricle: a multicenter study. J Am Heart Assoc. 2022 Nov 15;11(22):e025121. doi: 10.1161/JAHA.121.025121
  17. Fuentes Rojas S, Mondesert B, Raymond-Paquin A, et al. Advances in conduction system pacing and implications for congenital heart disease. Expert Rev Cardiovasc Ther. 2025 Dec;23(12):831-839. doi: 10.1080/14779072.2025.2586700
  18. Mayourian J, van Boxtel JPA, Sleeper LA, et al. Electrocardiogram-based deep learning to predict mortality in repaired tetralogy of Fallot. JACC Clin Electrophysiol. 2024 Dec;10(12):2600-2612. doi: 10.1016/j.jacep.2024.07.015
  19. Salvador M, Kong F, Peirlinck M, Parker DW, et al. Digital twinning of cardiac electrophysiology for congenital heart disease. J R Soc Interface. 2024 Jun;21(215):20230729. doi: 10.1098/rsif.2023.0729
  20. Labombarda F, Hamilton R, Shohoudi A, et al. Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease. J Am Coll Cardiol. 2017 Aug 15;70(7):857-865. doi: 10.1016/j.jacc.2017.06.034
  21. Khairy P, Aboulhosn J, Broberg CS, et al. Anticoagulation Therapy in Congenital Heart Disease i and the Alliance for Adult Research in Congenital C. Thromboprophylaxis for atrial arrhythmias in congenital heart disease: A multicenter study. Int J Cardiol. 2016 Nov 15;223:729-735. doi: 10.1016/j.ijcard.2016.08.223
  22. Casteigt B, Samuel M, Laplante L, et al.; of the APPROACH-IS Consortium and the International Society for Adult Congenital Heart Disease (ISACHD). Atrial arrhythmias and patient-reported outcomes in adults with congenital heart disease: An international study. Heart Rhythm. 2021 May;18(5):793-800. doi: 10.1016/j.hrthm.2020.09.012
  23. Triedman JK. Arrhythmias in adults with congenital heart disease. Heart. 2002 Apr;87(4):383-389. doi: 10.1136/heart.87.4.383
  24. Martin CA, Yue A, Martin R, et al. Ultra-high-density activation mapping to aid isthmus identification of atrial tachycardias in congenital heart disease. JACC Clin Electrophysiol. 2019 Dec;5(12):1459-1472. doi: 10.1016/j.jacep.2019.08.001
  25. Kamp AN, Nair K, Fish FA, Khairy P. Catheter ablation of atrial arrhythmias in patients post-Fontan. Can J Cardiol. 2022 Jul;38(7):1036-1047. doi: 10.1016/j.cjca.2022.02.023
  26. Moore JP, Gallotti RG, Tran E, Perens GS, Shannon KM. Ten-year outcomes of transcaval cardiac puncture for catheter ablation after extracardiac Fontan surgery. Heart Rhythm. 2020 Oct;17(10):1752-1758. doi: 10.1016/j.hrthm.2020.05.007
  27. Khairy P, Dyrda K, Mondesert B, et al. Overcoming access challenges to treat arrhythmias in patients with congenital heart disease using robotic magnetic-guided catheter ablation. J Clin Med. 2024 Sep 13;13(18):5432. doi: 10.3390/jcm13185432
  28. Bessiere F, Waldmann V, Combes N, et al. Ventricular arrhythmias in adults with congenital heart disease, Part I: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 Sep 12;82(11):1108-1120. doi: 10.1016/j.jacc.2023.06.034
  29. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004 Apr 27;109(16):1994-2000. doi: 10.1161/01.CIR.0000126495.11040.BD
  30. Kapel GF, Sacher F, Dekkers OM, et al. Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot. Eur Heart J. 2017 Jan 21;38(4):268-276. doi: 10.1093/eurheartj/ehw202
  31. Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008 Jan 22;117(3):363-370. doi: 10.1161/CIRCULATIONAHA.107.726372
  32. Kimura Y, Wallet J, Bouyer B, et al. Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot. Eur Heart J. 2024 Jun 14;45(23):2079-2094. doi: 10.1093/eurheartj/ehae268
  33. Khairy P. A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot. Eur Heart J. 2024 Jun 14;45(23):2095-2097. doi: 10.1093/eurheartj/ehae196
  34. Moore JP, Shannon KM, Khairy P, et al. Sinus rhythm QRS morphology reflects right ventricular activation and anatomical ventricular tachycardia isthmus conduction in repaired tetralogy of Fallot. Heart Rhythm. 2023 Dec;20(12):1689-1696. doi: 10.1016/j.hrthm.2023.08.020
  35. Moore JP, Aboulhosn JA, Zeppenfeld K, et al. Rationale and design of the multicenter catheter ablation of ventricular tachycardia before transcatheter pulmonary valve replacement in repaired tetralogy of Fallot study. Am J Cardiol. 2023 Oct 1;204:14-21. doi: 10.1016/j.amjcard.2023.07.087
  36. Feins EN, O’Leary ET, Hoganson DM, et al. Intraoperative conduction mapping in complex congenital heart surgery. JTCVS Tech. 2022 Feb 1;12:159-163. doi: 10.1016/j.xjtc.2021.11.017
  37. Grubb CS, Lewis M, Whang W, et al. Catheter ablation for atrial tachycardia in adults with congenital heart disease: Electrophysiological predictors of acute procedural success and post-procedure atrial tachycardia recurrence. JACC Clin Electrophysiol. 2019 Apr;5(4):438-447. doi: 10.1016/j.jacep.2018.10.011
  38. Campbell T, Haqqani H, Kumar S. Intracardiac echocardiography to guide mapping and ablation of arrhythmias in patients with congenital heart disease. Card Electrophysiol Clin. 2021 Jun;13(2):345-356. doi: 10.1016/j.ccep.2021.03.001
  39. Vo C, Bartoletti S, Benali K, et al. Robotic magnetic-guided catheter ablation in patients with congenital heart disease: a systematic review and pooled analysis. Expert Rev Cardiovasc Ther. 2023 Mar;21(3):227-236. doi: 10.1080/14779072.2023.2184798
  40. Avila P, Bessiere F, Mondesert B, et al. Cryoablation for perinodal arrhythmia substrates in patients with congenital heart disease and displaced atrioventricular conduction systems. JACC Clin Electrophysiol. 2018 Oct;4(10):1328-1337. doi: 10.1016/j.jacep.2018.05.026
  41. Abadir S, Waldmann V, Dyrda K, et al. Feasibility and safety of cryoballoon ablation for atrial fibrillation in patients with congenital heart disease. World J Cardiol. 2019 May 26;11(5):149-158. doi: 10.4330/wjc.v11.i5.149
  42. Krause U, Muller MJ, Schneider HE, Paul T. Catheter ablation of atrial fibrillation using 2nd-generation cryoballoon in congenital heart disease patients - significance of RF ablation of additional atrial macro-reentrant tachycardia. J Interv Card Electrophysiol. 2022 Nov;65(2):411-417. doi: 10.1007/s10840-022-01213-0
  43. Reddy VY, Gerstenfeld EP, Natale A, et al.; ADVENT Investigators. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023 Nov 2;389(18):1660-1671. doi: 10.1056/NEJMoa2307291
  44. Turagam MK, Neuzil P, Schmidt B, et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: One-year outcomes from the MANIFEST-PF registry. Circulation. 2023 Jul 4;148(1):35-46. doi: 10.1161/CIRCULATIONAHA.123.064959
  45. Ekanem E, Neuzil P, Reichlin T, et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med. 2024 Jul;30(7):2020-2029. doi: 10.1038/s41591-024-03114-3
  46. Khalil F, Deshmukh AJ, Tsai ST. Pulsed field ablation for atrial fibrillation in Fontan palliation. J Cardiovasc Electrophysiol. 2025 Sep;36(9):2437-2439. doi: 10.1111/jce.16795
  47. Ruwald MH, Johannessen A, Worck R, Hansen ML, Haugdal M, Hansen J. Feasibility and midterm effectiveness of focal pulsed field ablation for ventricular arrhythmias. Heart Rhythm. 2026 Jan;23(1):97-104. doi: 10.1016/j.hrthm.2025.02.014
  48. Khairy P, Fuentes Rojas S, Hermann Honfo S. Risk stratification for sudden death in congenital heart disease: bridging evidence, uncertainty, and individual decison-making. Curr Opin Cardiol. 2026 Jan 1:41(1):2-9. doi: 10.1097/HCO.0000000000001265
  49. Moore JP, Mondesert B, Lloyd MS, et al.; Alliance for Adult Research in Congenital Cardiology (AARCC). Clinical experience with the subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease. Circ Arrhythm Electrophysiol. 2016 Sep;9(9):e004338. doi: 10.1161/CIRCEP.116.004338
  50. Ferrero P, Ali H, Barman P, et al. Entirely subcutaneous defibrillator and complex congenital heart disease: Data on long-term clinical follow-up. World J Cardiol. 2017 Jun 26;9(6):547-552. doi: 10.4330/wjc.v9.i6.547
  51. Theuns D, Brouwer TF, Jones PW, et al. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2018 Oct 15;15(10):1515-1522. doi: 10.1016/j.hrthm.2018.05.011
  52. Mondesert B, Dubuc M, Khairy P, Guerra PG, Gosselin G, Thibault B. Combination of a leadless pacemaker and subcutaneous defibrillator: First in-human report. HeartRhythm Case Rep. 2015 Jul 30;1(6):469-471. doi: 10.1016/j.hrcr.2015.07.009
  53. Knops RE, Lloyd MS, Roberts PR, et al.; MODULAR ATP Investigators. A modular communicative leadless pacing-defibrillator system. N Engl J Med. 2024 Oct 17;391(15):1402-1412. doi: 10.1056/NEJMoa2401807
  54. Billakanty SR, Badin AG, Cline MJ, et al. Characteristics of extravascular implantable cardioverter-defibrillator implantation. JACC Clin Electrophysiol. 2025 Aug;11(8):1877-1879. doi: 10.1016/j.jacep.2025.05.004
  55. Deets A, Nelson DW, Nangia V, Lin A and Niazi I. First surgical epicardial implantation of an extravascular implantable cardioverter-defibrillator lead for Ebstein anomaly in the United States. HeartRhythm Case Rep. 2025 Aug;11(8):886-890. doi: 10.1016/j.jacep.2025.05.004
  56. Sherwin ED, Shah MJ. Leadless pacemakers in patients with congenital heart disease. Card Electrophysiol Clin. 2023 Dec;15(4):421-432. doi: 10.1016/j.ccep.2023.06.002
  57. Khairy P, Mondesert B, Mongeon FP, Poirier N, Thibault B. Leadless atrioventricular synchronous pacing in Eisenmenger syndrome. HeartRhythm Case Rep. 2021 May 5;7(8):538-541. doi: 10.1016/j.hrcr.2021.04.016
  58. Das S, Boe BA, Saef J, et al. Leadless Pacemaker Implantation in Fontan Patients with Multimodality Imaging: Tips and Tricks. J Innov Card Rhythm Manag. 2024 Aug 15;15(8):5990-5996. doi: 10.19102/icrm.2024.15082
  59. Ngan HTA, Fabbricatore D, Regan W, Rosenthal E, Wong T. Dual-chamber leadless pacemaker in complex adult congenital heart disease: a case report. Eur Heart J Case Rep. 2024 Sep 17;8(10):ytae506. doi: 10.1093/ehjcr/ytae506
  60. How-Peng Liu H, Cortez D. Retrievable dual-chamber leadless pacemaker implant (Aveir DR) in an adult patient with congenital heart disease. Indian Pacing Electrophysiol J. 2024 Nov-Dec;24(6):347-350. doi: 10.1016/j.ipej.2024.09.001
  61. Hughes E, Prica M, Calvert P, et al. Medium-Term Outcomes of Leadless Pacemaker Systems in Patients with an Extracardiac or Lateral Tunnel Fontan Circulation. J Am Coll Cardiol. 2025 Mar 28;85(12_Supplement).
  62. Moore JP, Dalal AS. Conduction System Pacing for Patients with Congenital Heart Disease. Card Electrophysiol Clin. 2023 Dec;15(4):457-466. doi: 10.1016/j.ccep.2023.06.009
  63. Moore JP, Gallotti R, Shannon KM, et al. Permanent conduction system pacing for congenitally corrected transposition of the great arteries: A Pediatric and Congenital Electrophysiology Society (PACES)/International Society for Adult Congenital Heart Disease (ISACHD) Collaborative Study. Heart Rhythm. 2020 Mar 13;S1547-5271(20)30088-6. doi: 10.1016/j.hrthm.2020.01.033
  64. Su J, Lam WW, Contractor A, Moore JP. Conduction System Pacing-Optimized Cardiac Resynchronization Therapy for Congenitally Corrected Transposition. JACC Case Rep. 2025 Feb 19;30(4):103000. doi: 10.1016/j.jaccas.2024.103000
  65. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003 May 13;107(18):2287-2289. doi: 10.1161/01.CIR.0000070930.33499.9F
  66. Janousek J, Kovanda J, Lozek M, et al. Pulmonary Right Ventricular Resynchronization in Congenital Heart Disease: Acute Improvement in Right Ventricular Mechanics and Contraction Efficiency. Circ Cardiovasc Imaging. 2017 Sep;10(9):e006424. doi: 10.1161/CIRCIMAGING.117.006424
  67. Sajja A, Ibrahim R, Pernetz M, Lloyd M. Right ventricular cardiac resynchronization therapy in patients with right ventricular conduction delay and heart failure. Heart Rhythm. 2023 May;20(5):760-765. doi: 10.1016/j.hrthm.2023.01.014
  68. Wijesuriya N, De Vere F, Howell S, et al. Potential applications of ultrasound-based leadless endocardial pacing in adult congenital heart disease. Heart Rhythm. 2025 Feb;22(2):546-553. doi: 10.1016/j.hrthm.2024.09.006
  69. Helm BM, Baud R, Shopp L, Kean AC, Ayers MD. Novel NKX2.5 variant associated with congenital heart disease and increased risk of malignant arrhythmia and sudden cardiac death. Cardiol Young. 2024 Mar;34(4):654-658. doi: 10.1017/S1047951123003219
  70. Moskowitz IP, Pizard A, Patel VV, et al. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. 2004 Aug;131(16):4107-4116. doi: 10.1242/dev.01265
  71. Diller GP, Orwat S, Vahle J, et al.; and German Competence Network for Congenital Heart Defects Investigators. Prediction of prognosis in patients with tetralogy of Fallot based on deep learning imaging analysis. Heart. 2020 Jul;106(13):1007-1014. doi: 10.1136/heartjnl-2019-315962
  72. Waight MC, Prakosa A, Li AC, et al. Personalized heart digital twins detect substrate abnormalities in scar-dependent ventricular tachycardia. Circulation. 2025 Feb 25;151(8):521-533. doi: 10.1161/CIRCULATIONAHA.124.070526
  73. Bhagirath P, Strocchi M, Bishop MJ, Boyle PM, Plank G. From bits to bedside: entering the age of digital twins in cardiac electrophysiology. Europace. 2024 Dec 3;26(12):euae295. doi: 10.1093/europace/euae295
DOI: https://doi.org/10.14797/mdcvj.1736 | Journal eISSN: 1947-6108
Language: English
Page range: 108 - 123
Submitted on: Nov 11, 2025
Accepted on: Dec 23, 2025
Published on: Jun 30, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2026 Stephanie Fuentes Rojas, Paul Khairy, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.